PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsCommentWho is afraid of more informed patients? Public fear mongering by the Swiss Academy of Medical Sciences

BioNews

Who is afraid of more informed patients? Public fear mongering by the Swiss Academy of Medical Sciences

Published 8 February 2013 posted in Comment and appears in BioNews 692

Authors

Dr Barbara Prainsack

Dr Daniela Steinberger

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.

The Swiss Academy of Medical Sciences' position paper on the 'Potential and Limits of "Individualised Medicine"' illustrates a concerning instance of public fear mongering based on factual mistakes and misinformation...

In December 2012 the Swiss Academy of Medical Sciences (SAMW) published a position paper on the 'Potential and Limits of "Individualised Medicine"' (1).  Instead of a critical discussion of the challenges and potential benefits of the current shift towards personalised medicine, as the position paper's title would suggest, it instead illustrates a concerning instance of public fear mongering based on factual mistakes and misinformation.

The paper states that some direct-to-consumer (DTC) genotyping services include prognostic information on fatal neurodegenerative diseases such as Huntington's disease. To the best of our knowledge, no provider of DTC genetic testing provides personalised genetic information on this disorder. Current high-throughput methods would not even be suitable for this purpose because of the specific type of mutation that causes Huntington's disease.

Another example for the kind of misinformation that characterises the position paper is the contention that family histories have a better predictive value for individual health and disease than genetic susceptibility testing. While we agree that family histories are an invaluable tool in clinical genetics, and for diagnosis more generally, the assertion that they are generally better predictors than genetic testing is problematic for at least two reasons.

Firstly, most carriers for recessively inherited diseases have no known family history of the disease. In such cases, a person's carrier status is not detectable on the basis of a family history; it would only become apparent once the affected person or biological relatives show clinical symptoms. Secondly, offering comprehensive family histories taken by a physician to every person is an unrealistic scenario, not least because of scarce resources.

The Academy's position paper also contains numerous unsubstantiated claims that seem to be geared towards spreading fear in the general public of developments challenging the clinical status quo. Warnings that, for example, medical professionals are not fully aware of their responsibilities towards the sensitive nature of data generated by personalised medicine, is prone to scare people off participating in data-rich medicine.

Of course we should not blindly buy into the claims of those who have stakes in the advancements of personalised medicine, most prominently, the claim that personalised medicine will save costs. Considering individual characteristics in prevention, diagnosis, treatment, and monitoring is likely to save costs in some cases, but increase costs in others. The same applies to the opportunities and limits of personalised medicine more generally. These cannot be assessed at a general level, but only in their specific institutional, technical, and practical configurations.

Two reports have recently taken on the challenge of mapping the conditions of the possibility, and the likely implications, of personalised medicine in a nuanced manner; one by the US National Academy of Sciences (2), and one by the European Science Foundation (3). It is noteworthy that the position paper of the Swiss Academy of Medical Sciences does not even mention these reports. Instead, it rehearses common prejudices and stereotypes related to the dangers of more informed patients. Scared patients, of course, are easier to govern.

The position paper does diagnose deficiencies in current knowledge of the science underpinning personalised medicine within the medical profession. This is indeed an important concern (4,5). The solution to this problem however cannot consist merely of the allocation of more resources to medical professionals within the healthcare system.

The translation of knowledge into health-improving practices in the clinic and beyond will require the distribution of knowledge using open access tools and web-based solutions wherever reasonably possible. Such a measure will provide a useful basis for fruitful collaborations between better informed patients and better prepared physicians.

Related Articles

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
Reviews
11 March 2013 • 4 minutes read

Event Review: Personal Genetics - An Intersection Between Science, Society, and Policy

by Cristy Gelling

In the decade since the human genome was first sequenced, the cost of reading a human genome has dropped from around US $100,000,000 to around US $6,000. In the past year the target has shifted from the '$1000 genome' to the '$0 genome'...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
Comment
13 February 2013 • 5 minutes read

Crystal ball gazing: an interview with Professor Sir John Burn on genetics in 2012

by Rebecca Hill

Genome sequencing for all, the abuse of stored genetic data and red tape halting research are just some of the issues the NHS will have to deal with this year, according to Sir John Burn, professor of clinical genetics at the University of Newcastle, chair of the British Society for Human Genetics (BSHG)...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
Reviews
5 February 2013 • 4 minutes read

Book Review: The Language of Life - DNA and the Revolution in Personalised Medicine

by Naomi Moskovic

The author of this book was head of the Human Genome Project at the time when the pioneering work to sequence the human genome was carried out. Furthermore, the cover of the paperback carries an endorsement of his work from no less than Barack Obama. So this is an important book...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
Reviews
19 November 2012 • 4 minutes read

Event Review: The Age of Personalised Medicine - Genes, Privacy and Discrimination

by Rebecca Hill

'The age of personalised medicine: genes, privacy and discrimination?' was the last in BioCentre's 2010/2011 symposium series 'Revolution, Regulation and Responsibilities', and promised to 'appraise current developments and consider the current legal and regulatory position for their use before taking time to reflect and assess the future impact on society'...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
Comment
2 November 2012 • 4 minutes read

Personalised medicine: a reality check

by Professor Donna Dickenson

The soaring promises made by personalised medicine advocates are probably loftier than in any other medical or scientific realm today. Francis Collins, former co-director of the Human Genome Project, wrote: 'We are on the leading edge of a true revolution in medicine, one that promises to transform the traditional "one size fits all" approach into a much more powerful strategy'...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
Comment
1 November 2012 • 3 minutes read

Will pharmacogenetics lead to colour-coded medicine?

by Nishat Hyder

'Will pharmacogenetics lead to colour-coded medicine?' was the question posed at the Progress Educational Trust (PET)'s panel discussion on 10 May 2011. This event, which is part of a wider project, 'Genes, ancestry and racial identity: Does it matter where your genes come from?' was held at the Foresight Centre, University of Liverpool...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« The demise of the HFEA - don't lament (or celebrate) too soon, it may never happen

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.

Find out how you can advertise here
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
25 July 2022 • 4 minutes read

Was the Women's Health Strategy worth the wait?

25 July 2022 • 5 minutes read

200 Years of Mendel: From Peas to Personalised Medicine

18 July 2022 • 5 minutes read

The birth of genetics: celebrating 200 years of Mendel

15 July 2022 • 2 minutes read

FILM: Prioritising Patient Safety – How to Minimise Risk in Fertility Treatment

11 July 2022 • 6 minutes read

Dutch Embryos Act under revision

1 August 2022 • 4 minutes read

Women's Health Strategy plans reflect rising needs of same-sex female couples

25 July 2022 • 4 minutes read

Was the Women's Health Strategy worth the wait?

25 July 2022 • 4 minutes read

Why the UK should extend the 14-day rule to 28 days

25 July 2022 • 5 minutes read

200 Years of Mendel: From Peas to Personalised Medicine

18 July 2022 • 5 minutes read

The birth of genetics: celebrating 200 years of Mendel

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856